On March 28, 2024, the University of Maryland, Baltimore Future of Work Committee held its third and final hybrid town hall. During the two hour event the committee reviewed recommendations and discussed whether specific recommendations were approved, rejected, or subject to further review. Roughly 30 in-person and 100 virtual attendees asked a wide range of questions about implementation plans and offered additional suggestions. Speakers included UMB Provost and Exec. VP Roger J. Ward, Chief Business and Finance Officer and VP Dawn M. Rhodes, and Chief Human Resources Officer Malika S. Monger.
More from Youtube
- 1:20HRT & Compounded Products: What Patients Should KnowNot all hormone replacement therapies are the same. Compounded products raise unique questions about safety and effectiveness.University of Maryland School of Medicine professor Audra Stinchcomb, PhD, RPh, FAAPS, FAIMBE, explains the latest insights — helping patients and providers make informed choices.This research is supported by the U.S. Food and Drug Administration (FDA).#BreakthroughsCantWait #HormoneTherapy #FDAResearch #UMBresearch #WomensHealth
- 1:46Hormone Replacement Therapy: Risks, Benefits & Compounded ProductsWhat should patients and providers know about hormone replacement therapy (HRT)?Audra Stinchcomb, PhD, RPh, FAAPS, FAIMBE, professor of pharmaceutical sciences at the University of Maryland School of Pharmacy, explains the risks, benefits, and what to consider with compounded hormone products.This research is supported by the U.S. Food and Drug Administration (FDA).Learn more about how UMB researchers are advancing science: https://vist.ly/45nuc#HormoneReplacementTherapy #BreakthroughsCantWaitUMB #UMBresearch #FDAResearch
- 0:34FDA-Supported Menopause Research: Finding Safer Relief | Breakthroughs Can’t WaitMenopause symptoms like hot flashes and fatigue disrupt millions of women’s lives. University of Maryland, Baltimore researchers, supported by the U.S. Food and Drug Administration (FDA), are studying safer and more effective ways to manage symptoms—backed by science, not myths.Because breakthroughs can’t wait.#BreakthroughsCantWaitUMB #MenopauseResearch #WomensHealth #FDAResearch #FDAScience #HealthyAging
- 6:05What if Medicines Delivered Through the Skin Were More Precise?Audra Stinchcomb, PhD, RPh, FAAPS, FAIMBE, is working to ensure drug delivery through the skin is safe and effective, and just the right dose — especially for menopausal medicines.Although transdermal patches help patients maintain consistency with drug therapies, it is critical to ensure patients receive just the right dose often over long periods of time.Learn more about this University of Maryland School of Pharmacy-led research at https://www.umaryland.edu/breakthroughs#FDA #BreakthroughsCantWaitUMB #Menopause #transdermalpatch
- 1:28How Global Health Research Protects America | Breakthroughs Can’t WaitCongress invests in global health research for one simple reason: diseases don’t stop at the ocean. By stopping outbreaks where they start, this UMB research protects Americans and strengthens global health security.Supported by the National Institutes of Health Fogarty International Center.#BreakthroughsCantWaitUMB #GlobalHealth #NIH #FogartyInternational #HealthSecurity #ResearchProtectsUs #Congress
- 1:08Building Ethical Research Capacity in The Gambia | Breakthroughs Can’t WaitGlobal health breakthroughs depend on more than science. They rely on ethical research that protects communities. In The Gambia, professionals are being trained in research ethics to ensure studies improve care and safeguard people.Supported by the NIH Fogarty International Center.#BreakthroughsCantWaitUMB #GlobalHealth #NIHResearch #FogartyInternational #TheGambia #ResearchEthics #HealthEquity
